Suppr超能文献

碘的饮食摄入、放射性碘治疗与间变性甲状腺癌。

Dietary iodine intake, therapy with radioiodine, and anaplastic thyroid carcinoma.

机构信息

Department of Surgical Oncology, Institute of Oncology Ljubljana, Ljubljana Slovenia.

Department of Pathology, Institute of Oncology Ljubljana, Ljubljana Slovenia.

出版信息

Radiol Oncol. 2020 May 2;54(2):187-193. doi: 10.2478/raon-2020-0023.

Abstract

Background Anaplastic thyroid cancer (ATC) is one of the most aggressive tumors. The aim of the study was to determine the correlation between a higher dietary intake of iodine, frequency of ATC and the characteristics of ATC, and to find out how often patients with ATC had a history of radioiodine (RAI) therapy. Patients and methods This retrospective study included 220 patients (152 females, 68 males; mean age 68 years) with ATC who were treated in our country from 1972 to 2017. The salt was iodinated with 10 mg of potassium iodide/ kg before 1999, and with 25 mg of potassium iodide/kg thereafter. The patients were assorted into 15-year periods: 1972-1986, 1987-2001, and 2002-2017. Results The incidence of ATC decreased after a higher iodination of salt (p = 0.04). Patients are nowadays older (p = 0.013) and have less frequent lymph node metastases (p = 0.012). The frequency of distant metastases did not change over time. The median survival of patients in the first, second, and third periods was 3, 4, and 3 months, respectively (p < 0.05). The history of RAI therapy was present in 7.7% of patients. Conclusions The number of patients with a history of RAI therapy did not change statistically over time. The incidence of ATC in Slovenia decreased probably because of higher salt iodination.

摘要

背景

间变性甲状腺癌(ATC)是最具侵袭性的肿瘤之一。本研究旨在确定碘的较高膳食摄入量与 ATC 的频率和特征之间的相关性,并确定有多少 ATC 患者有放射性碘(RAI)治疗史。

患者和方法

本回顾性研究纳入了 1972 年至 2017 年在我国治疗的 220 例 ATC 患者(女性 152 例,男性 68 例;平均年龄 68 岁)。1999 年之前,盐中添加 10 毫克/公斤的碘化钾,之后添加 25 毫克/公斤的碘化钾。将患者分为 15 年组:1972-1986 年、1987-2001 年和 2002-2017 年。

结果

盐的碘化程度增加后 ATC 的发病率降低(p = 0.04)。现在的患者年龄较大(p = 0.013),且淋巴结转移频率较低(p = 0.012)。远处转移的频率随时间没有变化。第一、第二和第三时期的患者中位生存时间分别为 3、4 和 3 个月(p < 0.05)。有 RAI 治疗史的患者占 7.7%。

结论

有 RAI 治疗史的患者人数随时间的推移没有统计学上的变化。斯洛文尼亚 ATC 的发病率下降可能是由于盐的碘化程度增加所致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/073e/7276647/5b4d4f221469/raon-54-187-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验